Abstract
Appropriate and rational modulation of innate immunity may enhance the therapeutic efficacy of emerging immune therapies for treating cancer. One of the crucial cells of innate immunity is the macrophage. The purpose of this article was to review those issues that suggest ways of exploiting macrophage local functions in immune therapy, and to discuss the suitability of low molecular-weight lipopolysaccharides as potent modulators of macrophage functions for immune therapy of cancer.
- Received June 30, 2004.
- Accepted July 27, 2004.
- Copyright© 2004 International Institute of Anticancer Research (Dr. John G. Delinassios), All rights reserved
In this issue
Jump to section
Related Articles
Cited By...
- Clinical Effects of Orally Administered Lipopolysaccharide Derived from Pantoea agglomerans on Malignant Tumors
- Oral Administration of Lipopolysaccharide of Acetic Acid Bacteria Protects Pollen Allergy in a Murine Model
- Innate Immunity Activated by Oral Administration of LPSp Is Phylogenetically Preserved and Developed in Broiler Chickens
- Effects of Interactions Between Intestinal Microbiota and Intestinal Macrophages on Health
- Interactions of human monocytes with TMVs (tumour-derived microvesicles)
- Oral Administration of Lipopolysaccharides for the Prevention of Various Diseases: Benefit and Usefulness
- Cytotoxic Effects of Activated Alveolar Macrophages on Lung Carcinoma Cells via Cell-to-Cell Contact and Nitric Oxide
- Intestinal Macrophages Involved in the Homeostasis of the Intestine Have the Potential for Responding to LPS
- Improvement of Allergic Dermatitis via Regulation of the Th1/Th2 Immune System Balance by Macrophages Activated with Lipopolysaccharide Derived from Pantoea agglomerans (IP-PA1)
- Intracellular Localization of CD14 Protein in Intestinal Macrophages
- Utility and Safety of LPS-based Fermented Flour Extract as a Macrophage Activator